Applied Therapeutics Inc (APLT) Earnings Report, Financial Results, Financial analysis

Applied Therapeutics Inc narrowed first quarter of 2023 net loss per share of $-0.18 compare to net loss per share of $-0.88 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.20 realized in previous quarter.

*first quarter of 2023*
Earnings Per Share	Revenues
$ -0.18	$ 11 Mill
$+0.70	$+11M

Applied Therapeutics Inc 's Revenue rose by 0 % in first quarter of 2023 (Mar 31 2023) year on year, to $11 million and advanced by sequentially.

Applied Therapeutics Inc is Expected to report next financial results on August 11, 2023.

More on APLT's Income Statement

APLT's NET INCOME

Applied Therapeutics Inc 's in thefirst quarter of 2023 recorded net loss of $-10.137 million, an improvement compare to net loss of $-23.121 million in I. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-14.429 million realized in previous quarter.

More on APLT's Growth

Applied Therapeutics Inc Inventories
APLT's Cash flow In thefirst quarter of 2023 company's net cash flow was $6 million

Earnings quality

Applied Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Applied Therapeutics Inc payed $ -1.08 cash per share, on a free-cash flow basis .

Company issued 18.51 million shares or 48.91 % in Mar 31 2023.

• More on APLT's Dividends

Market Capitalization (Millions)	73
Shares Outstanding (Millions)	56
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	11
Net Income (TTM) (Millions $)	-70
Cash Flow (TTM) (Millions $)	-15
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Applied Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Applied Therapeutics Inc had negative $ -1.08 cash flow per share, on a free-cash flow basis .

Company issued 18.51 million shares or 48.91 % in Mar 31 2023.

• More on APLT's Balance Sheets

Market Capitalization (Millions)	73
Shares Outstanding (Millions)	56
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	11
Net Income (TTM) (Millions $)	-70
Cash Flow (TTM) (Millions $)	-15
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Applied Therapeutics Inc

APLT's Financial Statements and Analysis